PAI LIFE SCIENCES INC — Department of Health and Human Services SBIR Phase I: 93
PAI LIFE SCIENCES INC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $597,953
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 93
- Solicitation
- PHS-2021-1
- NAICS
- —
- Place of performance
- WA
- Period
- —
Description
The proprietary combination adjuvants AS01 and AS04 are used in approved vaccines (Shingrix and Cervarix, respectively). Another successful adjuvant, GLA-SE, is currently in late-stage clinical trials. To make these classes of adjuvants available to vaccine developers, the contractor is developing functional mimics for low-cost and effective vaccines against emerging diseases and to address major health gaps worldwide.